GET THE APP

Predicting Outcomes in Advanced Penile Squamous Cell Carcinoma
Cancer Science & Therapy

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Opinion - (2025) Volume 17, Issue 2

Predicting Outcomes in Advanced Penile Squamous Cell Carcinoma

Enrique Cabrera*
*Correspondence: Enrique Cabrera, Department of Urology, Hospital Universitario 12 de Octubre, Madrid, Spain, Email:
1Department of Urology, Hospital Universitario 12 de Octubre, Madrid, Spain

Received: 01-Mar-2025, Manuscript No. jcst-25-168223; Editor assigned: 03-Mar-2025, Pre QC No. P-168223; Reviewed: 15-Mar-2025, QC No. Q-168223; Revised: 21-Mar-2025, Manuscript No. R-168223; Published: 29-Mar-2025 , DOI: 10.37421/1948-5956.2025.17.695
Citation: Cabrera, Enrique. “Predicting Outcomes in Advanced Penile Squamous Cell Carcinoma.” J Cancer Sci Ther 17 (2025): 695.
Copyright: © 2025 Cabrera E. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Introduction

Penile Squamous Cell Carcinoma (SCC) is a rare but aggressive malignancy, accounting for over 95% of all penile cancers. Its prognosis is significantly influenced by factors such as lymph node involvement, histologic grade, tumor thickness, perineural invasion and loco-regional spread. While early-stage disease often yields favorable outcomes with surgical intervention, advanced penile SCC presents significant diagnostic and therapeutic challenges. Mortality risk rises steeply with nodal metastasis and histopathologic aggressiveness, necessitating refined tools for accurate outcome prediction. Recent research has focused on developing and validating prognostic models using detailed pathologic staging and biological markers, aiming to support clinical decision-making, enhance survival estimates and tailor treatment strategies to individual patients [1].

Description

A major advancement in predicting outcomes in advanced penile SCC is the use of post-surgical loco-regional pathological staging to model cancer-specific mortality. Sun et al. (2015) developed a validated prognostic tool that incorporates multiple variables, such as nodal stage, extranodal extension and lymphovascular invasion. This model demonstrated a strong ability to predict cancer-specific survival, providing urologists and oncologists with a structured framework for patient counseling and treatment planning. Notably, the tool emphasized the significance of integrating comprehensive pathological data rather than relying solely on tumor size or depth of invasion. These tools are especially valuable in guiding the intensity of surveillance, adjuvant therapy decisions and consideration of pelvic lymphadenectomy in high-risk patients.

Complementing this, Velazquez et al. (2008) highlighted that histologic grade and perineural invasion are stronger predictors of nodal metastasis than tumor thickness in cases with 5-10 mm invasion. Their findings suggest that not all tumors with similar physical dimensions carry the same metastatic potential. This reinforces the importance of microscopic characteristics over macroscopic ones in determining prognosis. By identifying perineural invasion and poor differentiation as indicators of nodal spread, clinicians can more accurately stratify patients who may benefit from aggressive staging procedures or adjuvant treatments. Moreover, these insights shift the emphasis in pathology reporting and treatment algorithms toward biologically relevant features, moving beyond traditional TNM-based assessments [2].

Conclusion

Predicting outcomes in advanced penile squamous cell carcinoma requires a nuanced understanding of histopathologic and clinical variables. The integration of validated prognostic models and biologically significant markers such as perineural invasion and histologic grade has strengthened the precision of outcome predictions and personalized treatment strategies. These tools help distinguish patients at higher risk for recurrence or metastasis, enabling timely interventions and improved survival. As research continues to refine staging systems and predictive algorithms, clinicians will be better equipped to manage this challenging malignancy with evidence-based precision, ultimately enhancing both survival rates and quality of care for affected patients.

Acknowledgement

None.

Conflict of Interest

None.

References

  1. Sun, Maxine, Rosa S. Djajadiningrat, Hussain M. Alnajjar and Quoc�Dien Trinh, et al. "Development and external validation of a prognostic tool for prediction of cancer�specific mortality after complete loco�regional pathological staging for squamous cell carcinoma of the penis." BJU Int 116 (2015): 734-743.

Google Scholar Cross Ref Indexed at

  1. Velazquez, Elsa F., Gustavo Ayala, Hao Liu and Alcides Chaux, et al. "Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10 mm." The Am J Surg Pathol 32 (2008): 974-979.

Google Scholar Cross Ref Indexed at

Google Scholar citation report
Citations: 5332

Cancer Science & Therapy received 5332 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward